Pauline Reynier
Overview
Explore the profile of Pauline Reynier including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
287
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu Y, Platt R, Reynier P, Yu O, Filion K
Diabetes Obes Metab
. 2024 Dec;
27(2):976-986.
PMID: 39676749
Aims: Metformin is increasingly used off-label as the treatment of gestational diabetes (GDM). Our objective was to determine if metformin versus insulin initiation is associated with the adverse pregnancy outcomes....
2.
Dobromir Angheluta A, Levett J, Zolotarova T, Filion K, Seirafi T, Reynier P, et al.
JACC Adv
. 2024 Sep;
3(10):101204.
PMID: 39252859
Background: Drug-coated balloons (DCBs) may be a viable alternative to drug-eluting stents (DES) for de novo small caliber coronary artery lesions. However, there remains a lack of data regarding the...
3.
Alnuaimi A, Mach T, Reynier P, Filion K, Lipes J, Yu O
BMC Endocr Disord
. 2024 Aug;
24(1):133.
PMID: 39090718
Background: The purpose of this systematic review and meta-analysis was to synthesize the current literature to determine the safety and efficacy of using subcutaneous insulin compared to an intravenous (IV)...
4.
Moiz A, Levett J, Filion K, Peri K, Reynier P, Eisenberg M
Am J Cardiol
. 2024 Apr;
222:121-130.
PMID: 38679221
Semaglutide, a glucagon-like peptide-1 receptor agonist, has demonstrated clinically important weight loss effects in patients with type 2 diabetes. However, its effects on sustained weight loss in patients without diabetes...
5.
Masarwa R, Reynier P, Lefebvre C, Platt R, Delaney J, Filion K
Pharmacoepidemiol Drug Saf
. 2024 Feb;
33(2):e5752.
PMID: 38362652
Purpose: To describe the prescribing trends of proton pump inhibitors (PPIs) and H receptor antagonists (H RAs) among children with gastroesophageal reflux in the United Kingdom between 1998 and 2019....
6.
Levy A, Stock D, Paterson J, Tamim H, Chateau D, Quail J, et al.
CMAJ Open
. 2023 Nov;
11(6):E1033-E1040.
PMID: 37935487
Background: Ranitidine was the most prescribed histamine-2 receptor antagonist (HRA) in Canada when recalled in 2019 because of potential carcinogenicity. We sought to compare geographic and temporal patterns in use...
7.
Grandi S, Yu Y, Reynier P, Platt R, Yu O, Filion K
Paediatr Perinat Epidemiol
. 2023 Nov;
38(6):470-481.
PMID: 37921423
Background: While the benefits of levothyroxine are well-established for overt hypothyroidism, they are unclear for subclinical hypothyroidism (SCH) among pregnant women. Objective: To estimate the effect of initiation of levothyroxine...
8.
Prell C, Hebert-Losier A, Filion K, Reynier P, Eisenberg M
BMJ Open
. 2023 Oct;
13(10):e071099.
PMID: 37832989
Objectives: Expired carbon monoxide (ECO) is often used in smoking cessation trials to biochemically validate self-reported smoking status. The optimal ECO threshold to distinguish individuals who smoke from those who...
9.
Ayele H, Reynier P, Azoulay L, Platt R, Benayoun S, Filion K
Am J Med
. 2023 Jul;
136(10):1000-1010.e7.
PMID: 37481022
Background: Five-alpha reductase inhibitors (5αRIs) are used to treat benign prostatic hyperplasia (BPH). However, the cardiovascular effects of 5αRIs remain poorly understood. The study objective was to compare the rate...
10.
Levett J, Filion K, Reynier P, Prell C, Eisenberg M
Am J Med
. 2023 May;
136(8):804-813.e4.
PMID: 37148992
Background: People who smoke conventional cigarettes are increasingly turning to electronic cigarettes (e-cigarettes) as a pathway to quitting. However, the efficacy and safety of e-cigarettes for smoking cessation remains controversial....